Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ultralife ( (ULBI) ) has provided an announcement.
On July 16, 2025, Ultralife Corporation held its Annual Meeting of Stockholders, where stockholders elected five directors to serve for a one-year term. Additionally, the stockholders ratified Freed Maxick P.C. as the independent registered public accounting firm for 2025. The meeting saw a significant quorum with 85.35% of shares represented, indicating strong shareholder engagement.
The most recent analyst rating on (ULBI) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Ultralife stock, see the ULBI Stock Forecast page.
Spark’s Take on ULBI Stock
According to Spark, TipRanks’ AI Analyst, ULBI is a Outperform.
Ultralife’s overall stock score reflects solid financial performance and strong market momentum. The robust revenue growth and strategic initiatives are significant positive factors. However, the high valuation and concerns over declining margins and specific segment revenues weigh on the score.
To see Spark’s full report on ULBI stock, click here.
More about Ultralife
Ultralife Corporation operates in the technology and electronics industry, focusing on providing power solutions and communications systems. The company is known for its innovative products and services catering to sectors such as defense, aerospace, and medical industries.
Average Trading Volume: 114,909
Technical Sentiment Signal: Strong Buy
Current Market Cap: $142.4M
See more insights into ULBI stock on TipRanks’ Stock Analysis page.